Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-28

Clinical Trial Update: Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating transdermal testosterone pretreatment in poor responders undergoing IVF has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone transdermal (testosterone)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Subfertility | Phase 3 | Status: COMPLETED